Evidence map›Paper›PMID 26530863›Full record

ArticleAIDS and behavior2016

Early Adopters: Correlates of HIV Chemoprophylaxis Use in Recent Online Samples of US Men Who Have Sex with Men.

Kenneth H Mayer, Catherine E Oldenburg, David S Novak, Steven A Elsesser, Douglas S Krakower, Matthew J Mimiaga

Abstract read
In one paragraph

Article in AIDS and behavior, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kenneth H MayerThe Fenway Institute, Fenway Health, 1340 Boylston Street, Boston, MA, 02215, USA. kmayer@fenwayhealth.org.
Catherine E OldenburgThe Fenway Institute, Fenway Health, 1340 Boylston Street, Boston, MA, 02215, USA.
David S NovakOn-Line Buddies, Cambridge, MA, USA.
Steven A ElsesserThe Fenway Institute, Fenway Health, 1340 Boylston Street, Boston, MA, 02215, USA.
Douglas S KrakowerThe Fenway Institute, Fenway Health, 1340 Boylston Street, Boston, MA, 02215, USA.
Matthew J MimiagaThe Fenway Institute, Fenway Health, 1340 Boylston Street, Boston, MA, 02215, USA.

Funding

HIV and Other Infectious Consequences of Substance UseT32DA013911 · NIDA · MIRIAM HOSPITAL · PI TRACI C GREEN, JOSIAH D RICH · 2001 to 2026
$9.6M
Epidemiology of Infectious Diseases and BiodefenseT32AI007535 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI GRAD, YONATAN H, MURRAY, MEGAN B · 1998 to 2025
$4.8M
The Brown Initiative in HIV and AIDS Clinical Research for Minority CommunitiesR25MH083620 · NIMH · MIRIAM HOSPITAL · PI NUNN, AMY STEWART · 2008 to 2025
$3.7M
Optimizing HIV Pre-Exposure Prophylaxis through Shared Decision MakingK23MH098795 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KRAKOWER, DOUGLAS SCOTT · 2012 to 2016
$873k
NIAID NIH HHS T32 AI007535NIDA NIH HHS T32 DA013911NIMH NIH HHS K23 MH098795NIMH NIH HHS R25 MH083620
6 · The paper itself

Abstract

To date, little data on pre-exposure prophylaxis (PrEP) users outside of the clinical trial setting are available. A repeated cross-sectional survey of one of the largest social and sexual networking websites for men who have sex with men (MSM) in the United States was conducted in August 2013 (Wave 1) and January 2014 (Wave 2). Multivariable logistic regression models were used to assess factors associated with having heard of and having taken post-exposure prophylaxis (PEP) and PrEP in Wave 1 (N = 4043) and Wave 2 (N = 2737) separately. In Wave 1, 147 (3.6 %) and 61 (1.5 %) reported using PEP and PrEP, respectively, compared to 119 (4.4 %) and 62 (2.3 %) in Wave 2. Higher-risk sexual behaviors were associated with having taken PEP and PrEP, and previous PEP use was associated with having taken PrEP. Understanding factors that are associated with early use of PrEP may help inform wider utilization of PrEP by at risk MSM.

Indexed as

Post-Exposure ProphylaxisPre-Exposure ProphylaxisSexual BehaviorAdultAnti-HIV AgentsChemopreventionCross-Sectional StudiesHealth Knowledge, Attitudes, PracticeHIV InfectionsHomosexuality, MaleHumansInternetLogistic ModelsMaleMultivariate AnalysisRisk-TakingAnti-HIV AgentsHIV preventionMen who have sex with menPost-exposure prophylaxisPre-exposure prophylaxis

Identifiers

PMID26530863
PMCPMC4905561

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.